Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.52 |
| ▸ | APP | P05067 | 2/20 | 0.47 |
| ▸ | SNCA | P37840 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26552484 | 0.92 | MAPT (0.53) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL20603165 | 0.91 | PTGDR2 (0.52) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL30379922 | 0.91 | PTGDR2 (0.52) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL26552209 | 0.89 | MAPT (0.61) | MAPTAPPSNCAALDH1A1LMNA | |
| SCHEMBL30379648 | 0.86 | PTGDR2 (0.55) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL20603151 | 0.86 | PTGDR2 (0.55) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL20603161 | 0.83 | PTGDR2 (0.52) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL30379477 | 0.83 | PTGDR2 (0.52) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL20603191 | 0.82 | PTGDR2 (0.51) | MAPTPTGDR2APPSNCAALDH1A1 | |
| SCHEMBL30379551 | 0.82 | PTGDR2 (0.51) | MAPTPTGDR2APPSNCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025895-A1 | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-01-25 | — | — | US | disclosed |
| US-11787804-B2 | Compositions and methods for modulating hair growth | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787804-B2 | Compositions and methods for modulating hair growth | PC, FH, SLC25A1 | MAPT 2371/4885PTGDR2 1630/4885APP 2641/4885 |
| US-20240025895-A1 | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH | PC, FH, SLC25A1 | MAPT 2371/4885PTGDR2 1630/4885APP 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.